Table 2.

Characteristics of the patients after weighted by inverse probability of censoring/discharge at the beginning of the observation

	Regimen 1 (treated with remdesivir)	Regimen 2 (treated without remdesivir)	Standardized mean difference
Number	9,183	9,175
Age (years)	50.3 (21.5)	50.2 (21.5)	0.004
Male	52.3%	52.5%	0.002
Cardiovascular disease	4.1%	4.1%	<0.001
Respiratory disease	2.0%	2.0%	0.003
Diabetes mellitus	10.4%	10.4%	<0.001
Severe renal disease or dialysis	1.3%	1.3%	0.002
Hypertension	21.3%	21.1%	0.006
Obesity	6.5%	6.5%	0.003
Charlson Comorbidity Index	0.45 (0.95)	0.45 (0.95)	0.001
NEWS at Day 1	1.02 (1.17)	1.01 (1.17)	0.002
NEWS at Day 4	1.18 (1.34)	1.18 (1.34)	0.001
NEWS at Day 8	1.28 (1.58)	1.28 (1.57)	0.001
NEWS at Day 15	1.62 (2.01)	1.63 (2.02)	0.004
NEWS at Day 22	1.88 (2.39)	1.87 (2.38)	0.005
NEWS at Day 29	10.11 (1.92)	10.13 [1.96]	0.011
Fatal cases	1.7%	1.7%	<0.001
Oxygen administration during hospitalization*	9.4%	9.4%	0.001
IMV/ECMO during hospitalization	0.5%	0.5%	0.001
Days from symptom onset to hospitalization	2.62 (1.60)	2.62 (1.60)	<0.001
Use of systemic steroids	9.6%	9.5%	0.005
Use of favipiravir	9.4%	9.4%	0.002
Use of tocilizumab	0.4%	0.4%	<0.001
Use of baricitinib	0 (0%)	0 (0%)	<0.001

Regimen 1: treated with remdesivir.

Regimen 2: treated without remdesivir.

Continuous variables are presented mean (standard deviation). Categorical variables are presented in percentage.

IMV/ECMO = invasive mechanical ventilation/extracorporeal membrane oxygenation; NEWS = national early warning score.